Posted in | News | Laser | Medical Optics

Lumenis Unveils Advanced Ophthalmic Laser Delivery Technology

Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.

Dov Ofer, Lumenis' President and Chief Executive Officer stated: "Lumenis is proud to be yet again at the forefront of ophthalmic laser technology with the introduction of InSight®, a fully integrated, advanced retinal laser delivery technology and slit lamp bio-microscope. This achievement continues Lumenis' 40-year history of ophthalmic laser innovation. In 1970 we were the very first company to introduce a laser in this field; since then, we have followed with a series of additional sight-preserving milestones, including the first laser photocoagulator, laser indirect ophthalmoscope, multicolor photocoagulator, photodynamic (PDT) laser, the revolutionary Selective Laser Trabeculoplasty (SLT) system, and solid state multicolor laser."

"At this year's AAO Meeting, we continue this long-standing tradition as we proudly showcase the newest addition to our existing and already robust product portfolio of ophthalmic lasers and delivery devices. Our InSight represents the latest in retina visualization and laser delivery technology, and it successfully addresses some of the well-known challenges in ophthalmic laser delivery devices, namely, clear visualization of the retina and precise laser delivery to the target tissue," said Dov Ofer.

"We are very excited to significantly expand our capabilities in the Retina segment with the introduction of InSight," said Mr. Lloyd Diamond, Vice President & General Manager of Lumenis Vision, the ophthalmic business unit of Lumenis. "The InSight was designed to truly elevate performance and precision to new levels - allowing general ophthalmologists and retina specialists to customize each treatment and exercise complete control throughout the laser procedure. This ability is achieved through our unique and patented co-linear optical design, which projects both illumination and laser beam through the same pathway. Furthermore, the CoLin mechanism is controlled directly through InSight's integrated joystick, which also features our patented AcuGuide(TM) technology for fine movement and beam manipulation. With this technology, our customers can command complete control of the laser procedure literally with their fingertip."

"The InSight significantly facilitates laser delivery to the retina. Whether you are performing pan-retinal photocoagulation or a macular focal or grid laser treatment, the InSight provides you with complete control throughout the procedure, making the procedure easier for the treating physician," stated Dr. Pazit Pianka MD, an Ophthalmologist and Medical Director of Lumenis Vision.

In addition to incorporating the most advanced laser delivery and optics technology, ergonomic factors play a key role in the product design, as we recognize the tremendous benefit these represent to ophthalmologists and their patients. "The InSight is a valuable addition to the Lumenis ophthalmic product portfolio, further enhancing and protecting our global leadership position in the markets we serve," concluded Mr. Diamond.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.